{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:29:05Z","timestamp":1793521745815,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["22\/508"],"award-info":[{"award-number":["22\/508"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.chest.2025.08.014","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:22:44Z","timestamp":1756945364000},"page":"1304-1316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Dose-Response of Inhaled Corticosteroids in Combination Inhaled Corticosteroid\/Long Acting Beta2-Agonist Maintenance Therapy for Asthma"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7620-3125","authenticated-orcid":false,"given":"Jonathan H.","family":"Noble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Warhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Sayers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kulathinal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Weatherall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2025.08.014_bib1","series-title":"Global Strategy for Asthma Management and Prevention","year":"2025"},{"issue":"1","key":"10.1016\/j.chest.2025.08.014_bib2","first-page":"16","article-title":"Clinical dose-response relationship of fluticasone propionate in adults with asthma","volume":"59","author":"Masoli","year":"2004","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.chest.2025.08.014_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1183\/09031936.04.00076604","article-title":"Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis","volume":"23","author":"Masoli","year":"2004","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.chest.2025.08.014_bib4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1164\/rccm.201810-1868CI","article-title":"Inhaled corticosteroid therapy in adult asthma. Time for a new therapeutic dose terminology","volume":"199","author":"Beasley","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2025.08.014_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.202402-0368OC","article-title":"Association of dose of inhaled corticosteroids and frequency of adverse events","volume":"211","author":"Bloom","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.chest.2025.08.014_bib6","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study","volume":"170","author":"Bateman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.chest.2025.08.014_bib7","first-page":"CD013797","article-title":"Addition of long-acting beta2 agonists or long-acting muscarinic antagonists vs doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis","volume":"8","author":"Oba","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.chest.2025.08.014_bib8","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.chest.2025.08.014_bib9","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.chest.2025.08.014_bib10","series-title":"GRADE handbook for grading quality of evidence and strength of recommendations","year":"2013"},{"key":"10.1016\/j.chest.2025.08.014_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jclinepi.2020.11.003","article-title":"Machine learning reduced workload with minimal risk of missing studies: development and evaluation of a randomized controlled trial classifier for Cochrane Reviews","volume":"133","author":"Thomas","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.chest.2025.08.014_bib12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3109\/02770903.2015.1056350","article-title":"Fluticasone furoate (FF)\/vilanterol (100\/25 mcg or 200\/25 mcg) or FF (100 mcg) in persistent asthma","volume":"52","author":"Bernstein","year":"2015","journal-title":"J Asthma"},{"issue":"6","key":"10.1016\/j.chest.2025.08.014_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/thoraxjnl-2012-202606","article-title":"Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the beta2 agonist vilanterol administered once daily for 52 weeks in patients \u226512 years old with asthma: a randomised trial","volume":"68","author":"Busse","year":"2013","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.chest.2025.08.014_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.rmed.2010.04.001","article-title":"Effect of salmeterol\/fluticasone propionate combination on airway hyper-responsiveness in patients with well-controlled asthma","volume":"104","author":"Chanez","year":"2010","journal-title":"Respir Med"},{"issue":"10","key":"10.1016\/j.chest.2025.08.014_bib15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S2213-2600(20)30190-9","article-title":"Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study","volume":"8","author":"Kerstjens","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2025.08.014_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.chest.2025.08.014_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2500\/aap.2010.31.3381","article-title":"Twelve-week efficacy and safety study of mometasone furoate\/formoterol 200\/10 microg and 400\/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids","volume":"31","author":"Weinstein","year":"2010","journal-title":"Allergy Asthma Proc"},{"issue":"10","key":"10.1016\/j.chest.2025.08.014_bib18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S2213-2600(20)30178-8","article-title":"Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study","volume":"8","author":"van Zyl-Smit","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2025.08.014_bib19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2500\/aap.2015.36.3886","article-title":"Randomized equivalence trial: a novel multidose dry powder inhaler and originator device in adult and adolescent asthma","volume":"36","author":"Kuna","year":"2015","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.chest.2025.08.014_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.rmed.2012.10.025","article-title":"Efficacy and safety of fluticasone\/formoterol combination therapy in patients with moderate-to-severe asthma","volume":"107","author":"Corren","year":"2013","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.chest.2025.08.014_bib21","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.rmed.2008.03.014","article-title":"Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study","volume":"102","author":"Godard","year":"2008","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2025.08.014_bib22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaip.2017.07.030","article-title":"Step-down therapy for asthma well controlled on inhaled corticosteroid and long-acting beta-agonist: a randomized clinical trial","volume":"6","author":"Rogers","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.chest.2025.08.014_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2500\/aap.2017.38.4069","article-title":"Fluticasone propionate and fluticasone propionate\/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma","volume":"38","author":"Sher","year":"2017","journal-title":"Allergy Asthma Proc"},{"issue":"156","key":"10.1016\/j.chest.2025.08.014_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0137-2019","article-title":"Minimal clinically important difference for asthma endpoints: an expert consensus report","volume":"29","author":"Bonini","year":"2020","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.chest.2025.08.014_bib25","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2025.08.014_bib26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.06.053","article-title":"The minimally important difference of the Asthma Control Test","volume":"124","author":"Schatz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.chest.2025.08.014_bib27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jaci.2023.12.006","article-title":"Is the assessment of asthma treatment efficacy sufficiently comprehensive?","volume":"153","author":"Stempel","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.chest.2025.08.014_bib28","first-page":"CD013799","article-title":"Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis","volume":"12","author":"Oba","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.chest.2025.08.014_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2500\/aap.2008.29.3147","article-title":"Long-term safety and asthma control with budesonide\/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients","volume":"29","author":"Peters","year":"2008","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.chest.2025.08.014_bib30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2500\/aap.2017.38.4061","article-title":"A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate\/salmeterol multidose dry powder inhalers in persistent asthma","volume":"38","author":"Mansfield","year":"2017","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.chest.2025.08.014_bib31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jaip.2022.10.040","article-title":"Effect of stepping up to high-dose inhaled corticosteroids in patients with asthma: UK Database Study","volume":"11","author":"Pavord","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.chest.2025.08.014_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaip.2023.09.034","article-title":"comorbidity burden in severe and nonsevere asthma: a nationwide observational study (FINASTHMA)","volume":"12","author":"Kankaanranta","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.chest.2025.08.014_bib33","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jaip.2025.01.023","article-title":"Use of high-dose inhaled corticosteroids and risk of corticosteroid-related adverse events in asthma findings from the NORDSTAR cohort","volume":"13","author":"von Bulow","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.chest.2025.08.014_bib34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1164\/rccm.201904-0903SO","article-title":"Systematic literature review of systemic corticosteroid use for asthma management","volume":"201","author":"Bleecker","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2025.08.014_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41533-024-00402-w","article-title":"Burden of illness among patients with asthma prescribed inhaled corticosteroids\/long-acting beta(2)-agonists","volume":"35","author":"Zhang","year":"2025","journal-title":"NPJ Prim Care Respir Med"},{"issue":"14","key":"10.1016\/j.chest.2025.08.014_bib36","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.2018.2769","article-title":"Association of inhaled corticosteroids and long-acting beta-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.chest.2025.08.014_bib37","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201903-0599LE","article-title":"Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide, and their combination in severe asthma: a post hoc analysis","volume":"200","author":"Shrimanker","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2025.08.014_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thoraxjnl-2021-217325","article-title":"Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.chest.2025.08.014_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.rmed.2006.07.005","article-title":"Recent asthma exacerbations: a key predictor of future exacerbations","volume":"101","author":"Miller","year":"2007","journal-title":"Respiratory Medicine"},{"issue":"1","key":"10.1016\/j.chest.2025.08.014_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12890-017-0409-3","article-title":"The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA","volume":"17","author":"Suruki","year":"2017","journal-title":"BMC Pulm Med"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369225051451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369225051451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:01:11Z","timestamp":1773302471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369225051451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0012369225051451"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2025.08.014","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Dose-Response of Inhaled Corticosteroids in Combination Inhaled Corticosteroid\/Long Acting Beta2-Agonist Maintenance Therapy for Asthma","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2025.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}